Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Frontiers in Oncology|March 27, 2023
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)Marinda Meertens, M Benthe Muntinghe-Wagenaar, Barend J Sikkema, et al.
Targeted Oncology|April 20, 2023
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung CancerRob Ter Heine, Michel M van den Heuvel, Berber Piet, et al.
The New England Journal of Medicine|August 21, 2009
Screening for epidermal growth factor receptor mutations in lung cancerRafael Rosell, Teresa Moran, Cristina Queralt, et al.
The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.
NPJ Precision Oncology|July 9, 2026
Development of a rapid ex vivo tumor platform for drug response prediction in lung cancerRianne D W Vaes, Zhongli Chen, Iris E W G Laven, et al.
The Oncologist|January 23, 2025
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancerFerdinandos Skoulidis, Bob T Li, Maximilian Hochmair, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 10, 2019
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus ReportAnne-Marie C Dingemans, Lizza E L Hendriks, Thierry Berghmans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutationsRafael Rosell, Miguel Angel Molina, Carlota Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2026
Decoding B Cell Signatures of Complete Pathological Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung CancerBelén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre, et al.
Molecular Oncology|November 25, 2020
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancerCristina Aguado, Cristina Teixido, Ruth Román, et al.
Pageof 22